Composition to treat and/or prevent gastrointestinal infection
US-9078466-B2 · Jul 14, 2015 · US
Human milk oligosaccharides for modulating inflammation
US9283240B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9283240-B2 |
| Application number | US-201113335018-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 22, 2011 |
| Priority date | Dec 31, 2010 |
| Publication date | Mar 15, 2016 |
| Grant date | Mar 15, 2016 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Disclosed are nutritional compositions including human milk oligosaccharides that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases.
First claim
Opening claim text (preview).
What is claimed is: 1. A method to reduce inflammation in an infant, toddler, or child in need thereof, the method comprising administering to the infant, toddler, or child a nutritional composition comprising the human milk oligosaccharide lacto-N-neotetraose in a concentration of from about 0.001 mg/mL to 0.1 mg/mL. 2. The method of claim 1 , wherein the inflammation is respiratory inflammation. 3. The method of claim 1 , wherein the inflammation is selected from the group consisting of respiratory syncytial virus-induced inflammation, enteric inflammation, nasopharyngeal inflammation, and combinations thereof. 4. The method of claim 1 , wherein the composition further comprises from 0.001 mg/mL to less than 0.25 mg/mL 6′-sialylallactose. 5. The method of claim 1 , wherein the composition further comprises from 0.001 mg/mL to less than 0.15 mg/mL 3′-sialylallactose. 6. The method of claim 1 , wherein the composition further comprises 3′-sialyllactose and 6′-sialyllactose in a weight ratio of 3′-sialyllactose to 6′-sialyllactose of from about 1:20 to about 20:1. 7. The method of claim 1 , wherein the composition further comprises 3′-sialyllactose and 6′-sialyllactose in a weight ratio of 3′-sialyllactose to 6′-sialyllactose of from about 1:2 to about 2:1.
Assignees
Inventors
Classifications
Free radical scavengers or antioxidants · CPC title
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] · CPC title
Antivirals · CPC title
for influenza or rhinoviruses · CPC title
for RNA viruses · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9283240B2 cover?
- Disclosed are nutritional compositions including human milk oligosaccharides that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases.
- Who is the assignee on this patent?
- Buck Rachael, Duska-Mcewen Geralyn O, Schaller Joseph P, and 1 more
- What technology area does this patent fall under?
- Primary CPC classification A61K31/7016. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Mar 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).